Sandip Pawar

Dr. Sandip Pawar

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2022 in Future Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
JGJivesh Garg
Jivesh Garg
KPKhushboo Pathania
Khushboo Pathania
SSSangeeta Pilkhwal Sah
Sangeeta Pilkhwal Sah
SPSandip Pawar
Sandip Pawar
Background: In recent years, the field of nanotechnology and nanomedicine has transformed the pharmaceutical industry with the development of novel drug delivery systems that overcome the shortcomings of traditional drug delivery systems. Nanostructured lipid carriers (NLCs), also known as the second-generation lipid nanocarriers, are one such efficient and targeted drug delivery system that has gained immense attention all across due to their myriad advantages and applications. Scientific advancements have revolutionized our health system, but still, brain diseases like brain tumour have remained formidable owing to poor prognosis and the challenging drug delivery to the brain tissue. In this review, we highlighted the application and potential of NLCs in brain-specific delivery of chemotherapeutic agents.Main body: NLCs are lipid-based formulations with a solid matrix at room temperature and offer advantages like enhanced stability, low toxicity, increased shelf life, improved drug loading capacity, and biocompatibility over other conventional lipid-based nanocarriers such as nanoemulsions and solid lipid nanoparticles. This review meticulously articulates the structure, classification, components, and various methods of preparation exemplified with various research studies along with their advantages and disadvantages. The concept of drug loading and release has been discussed followed by a brief about stability and strategies to improve stability of NLCs. The review also summarizes variousin vitroand in vivo research studies on NLCs encapsulated with cytotoxic drugs and their potential application in brain-specific drug delivery.Conclusion: NLCs are employed as an important carrier for the delivery of food, cosmetics, and medicines and recently have been used in brain targeting, cancer, and gene therapy. However, in this review, the applications and importance of NLCs in targeting brain tumour have been discussed in detail stating examples of various research studies conducted in recent years. In addition, to shed light on the promising role of NLCs, the current clinical status of NLCs has also been summarized.Graphical

26 April 2023 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
YMYashdeep Mukheja
Yashdeep Mukheja
JKJaspreet Kaur
Jaspreet Kaur
KPKhushboo Pathania
Khushboo Pathania
SSSangeeta P. Sah
Sangeeta P. Sah
DSDeepak B. Salunke
Deepak B. Salunke
SPSandip Pawar
Sandip Pawar
1

1 September 2010 in Bioresource Technology
Verified
Journal Article
Closed access
SKSandeep Kumar
Sandeep Kumar
UMUtpal Mohan
Utpal Mohan
AKAshwini L. Kamble
Ashwini L. Kamble
SPSandip Pawar
Sandip Pawar
UBUttam Chand Banerjee
Uttam Chand Banerjee

2 January 2023 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
KPKhushboo Pathania
Khushboo Pathania
SSSangeeta P. Sah
Sangeeta P. Sah
DSDeepak B. Salunke
Deepak B. Salunke
MJManish Jain
Manish Jain
AYAshok Kumar Yadav
Ashok Kumar Yadav
SPSandip Pawar
Sandip Pawar

27 May 2025 in Sustainable Food Technology
Verified
Journal Article
Open access
PDF file
JMJhalak Mehta
Jhalak Mehta
KPKhushboo Pathania
Khushboo Pathania
SPSandip Pawar
Sandip Pawar
Nutraceuticals and dietary supplements have experienced a remarkable surge in demand over the past decade, driven by growing emphasis on preventive healthcare and heightened consumer preference for bioactive products. Nutraceuticals serve as an interface between pharmaceuticals and bioactives, offering therapeutic potential with minimal adverse effects. However, their clinical applications are often hindered by their inherent physicochemical characteristics, including low bioavailability, susceptibility to environmental degradation, poor aqueous solubility, instability, and post-delivery structural degradation. To address these challenges, nanotechnology has emerged as a promising avenue for enhancing the therapeutic efficacy and bioavailability of nutraceuticals. Nano-sized cargos such as liposomes, nanoparticles, nano-emulsions, and nanogels enable improved encapsulation, stability, bioavailability, cellular internalization, and targeted delivery of nutraceuticals. Furthermore, the sustainable manufacturing of nutraceuticals has undergone substantial technological advancements to enhance the bioavailability, therapeutic effect, and long-term stability. This review provides a comprehensive overview of recently published literature addressing different nano-enabled approaches employed for nutraceuticals, highlighting their targeted applications in disease prevention and management. Additionally, it critically examines the regulatory challenges associated with their production scalability, safety concerns, and environmental impact, while offering insights into existing regulatory frameworks and future considerations for the pervasive use of nanotechnology in the nutraceutical industry.

20 February 2020 in RSC Advances
Verified
Journal Article
Open access
PDF file
YNYerramsetti Nanaji
Yerramsetti Nanaji
SKSeema Kirar
Seema Kirar
SPSandip Pawar
Sandip Pawar
AYAshok Kumar Yadav
Ashok Kumar Yadav
A simple synthetic strategy has been developed for the synthesis of 2- and 1-alkyl/aryl/dialkylaminoquinolines and isoquinolines from the easily available quinoline and isoquinoline-N-oxides, different amines, triflic anhydride as activating agent and acetonitrile as solvent in a one-pot reaction under metal-free conditions at 0 °C to room temperature.